These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 25283138

  • 1. Salivary morning androstenedione and 17α-OH progesterone levels in childhood and puberty in patients with classic congenital adrenal hyperplasia.
    de Groot MJ, Pijnenburg-Kleizen KJ, Thomas CM, Sweep FC, Stikkelbroeck NM, Otten BJ, Claahsen-van der Grinten HL.
    Clin Chem Lab Med; 2015 Feb; 53(3):461-8. PubMed ID: 25283138
    [Abstract] [Full Text] [Related]

  • 2. Monitoring medical treatment in adolescents and young adults with congenital adrenal hyperplasia: utility of salivary 17α-hydroxyprogesterone day profiles.
    Deutschbein T, Unger N, Hauffa BP, Schaaf K, Mann K, Petersenn S.
    Exp Clin Endocrinol Diabetes; 2011 Mar; 119(3):131-8. PubMed ID: 20690075
    [Abstract] [Full Text] [Related]

  • 3. Salivary and plasma androstenedione and 17-hydroxyprogesterone levels in congenital adrenal hyperplasia.
    Otten BJ, Wellen JJ, Rijken JC, Stoelinga GB, Benraad TJ.
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1150-4. PubMed ID: 6605355
    [Abstract] [Full Text] [Related]

  • 4. Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry.
    Lawrence N, Bacila I, Dawson J, Bryce J, Ali SR, van den Akker ELT, Bachega TASS, Baronio F, Birkebaek NH, Bonfig W, van der Grinten HC, Costa EC, de Vries L, Elsedfy H, Güven A, Hannema S, Iotova V, van der Kamp HJ, Clemente M, Lichiardopol CR, Milenkovic T, Neumann U, Nordenström A, Poyrazoğlu Ş, Probst-Scheidegger U, De Sanctis L, Tadokoro-Cuccaro R, Thankamony A, Vieites A, Yavaş Z, Faisal Ahmed S, Krone N.
    Clin Endocrinol (Oxf); 2022 Nov; 97(5):551-561. PubMed ID: 35781728
    [Abstract] [Full Text] [Related]

  • 5. Isolated precocious pubarche: an approach.
    Balducci R, Boscherini B, Mangiantini A, Morellini M, Toscano V.
    J Clin Endocrinol Metab; 1994 Aug; 79(2):582-9. PubMed ID: 8045980
    [Abstract] [Full Text] [Related]

  • 6. Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia.
    Stikkelbroeck NM, Oyen WJ, van der Wilt GJ, Hermus AR, Otten BJ.
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1036-42. PubMed ID: 12629082
    [Abstract] [Full Text] [Related]

  • 7. Liquid chromatography-tandem mass spectrometric method for determination of salivary 17alpha-hydroxyprogesterone: a noninvasive tool for evaluating efficacy of hormone replacement therapy in congenital adrenal hyperplasia.
    Shibayama Y, Higashi T, Shimada K, Kashimada K, Onishi T, Ono M, Miyai K, Mizutani S.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May 01; 867(1):49-56. PubMed ID: 18378505
    [Abstract] [Full Text] [Related]

  • 8. Salivary Profiles of 11-oxygenated Androgens Follow a Diurnal Rhythm in Patients With Congenital Adrenal Hyperplasia.
    Nowotny HF, Auer MK, Lottspeich C, Schmidt H, Dubinski I, Bidlingmaier M, Adaway J, Hawley J, Keevil B, Reisch N.
    J Clin Endocrinol Metab; 2021 Oct 21; 106(11):e4509-e4519. PubMed ID: 34165575
    [Abstract] [Full Text] [Related]

  • 9. Relationships of basal level of serum 17-hydroxyprogesterone with that of serum androstenedione and their stimulated responses to a low dose of ACTH in young adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Kang MJ, Kim SM, Lee YA, Shin CH, Yang SW.
    J Korean Med Sci; 2011 Nov 21; 26(11):1454-60. PubMed ID: 22065901
    [Abstract] [Full Text] [Related]

  • 10. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.
    Pang S, MacGillivray M, Wang M, Jeffries S, Clark A, Rosenthal I, Wiegensberg M, Riddick L.
    J Clin Endocrinol Metab; 1991 Jul 21; 73(1):166-74. PubMed ID: 2045467
    [Abstract] [Full Text] [Related]

  • 11. Simultaneous plasma and saliva steroid measurements as an index of control in congenital adrenal hyperplasia (CAH). A longitudinal study.
    Hughes IA, Read GF.
    Horm Res; 1982 Jul 21; 16(3):142-50. PubMed ID: 7106699
    [Abstract] [Full Text] [Related]

  • 12. Diurnal salivary androstenedione and 17-hydroxyprogesterone levels in healthy volunteers for monitoring treatment efficacy of patients with congenital adrenal hyperplasia.
    Adriaansen BPH, Kamphuis JS, Schröder MAM, Olthaar AJ, Bock C, Brandt A, Stikkelbroeck NMML, Lentjes EGWM, Span PN, Sweep FCGJ, Claahsen-van der Grinten HL, van Herwaarden AE.
    Clin Endocrinol (Oxf); 2022 Jul 21; 97(1):36-42. PubMed ID: 35150157
    [Abstract] [Full Text] [Related]

  • 13. Evaluating the four most important salivary sex steroids during male puberty: testosterone best characterizes pubertal development.
    Krebs A, Dickhuth K, Mumm R, Stier B, Doerfer J, Grueninger D, Wurm M, Brichta C, Schwab KO.
    J Pediatr Endocrinol Metab; 2019 Mar 26; 32(3):287-294. PubMed ID: 30811345
    [Abstract] [Full Text] [Related]

  • 14. Monitoring of menstrual cycles, ovulation, and adrenal suppression by saliva sampling in female patients with 21-hydroxylase deficiency.
    Stikkelbroeck NM, Sweep CG, Braat DD, Hermus AR, Otten BJ.
    Fertil Steril; 2003 Oct 26; 80(4):1030-6. PubMed ID: 14556829
    [Abstract] [Full Text] [Related]

  • 15. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
    Theintz GE, Sizonenko PC.
    Arch Fr Pediatr; 1985 Mar 26; 42(3):211-7. PubMed ID: 4004483
    [Abstract] [Full Text] [Related]

  • 16. Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers.
    Debono M, Mallappa A, Gounden V, Nella AA, Harrison RF, Crutchfield CA, Backlund PS, Soldin SJ, Ross RJ, Merke DP.
    Eur J Endocrinol; 2015 Dec 26; 173(6):727-37. PubMed ID: 26340969
    [Abstract] [Full Text] [Related]

  • 17. Androstenedione rhythms in saliva in congenital adrenal hyperplasia.
    Young MC, Walker RF, Riad-Fahmy D, Hughes IA.
    Arch Dis Child; 1988 Jun 26; 63(6):624-8. PubMed ID: 3389892
    [Abstract] [Full Text] [Related]

  • 18. Measurement of Salivary Adrenal-Specific Androgens as Biomarkers of Therapy Control in 21-Hydroxylase Deficiency.
    Bacila I, Adaway J, Hawley J, Mahdi S, Krone R, Patel L, Alvi S, Randell T, Gevers E, Dattani M, Cheetham T, Kyriakou A, Schiffer L, Ryan F, Crowne E, Davies JH, Ahmed SF, Keevil B, Krone N.
    J Clin Endocrinol Metab; 2019 Dec 01; 104(12):6417-6429. PubMed ID: 31361321
    [Abstract] [Full Text] [Related]

  • 19. Correlation between androstenedione and 17-hydroxyprogesterone levels in the saliva and plasma of patients with congenital adrenal hyperplasia.
    Juniarto AZ, Goossens K, Setyawati BA, Drop SL, de Jong FH, Faradz SM.
    Singapore Med J; 2011 Nov 01; 52(11):810-3. PubMed ID: 22173250
    [Abstract] [Full Text] [Related]

  • 20. Adrenarche and puberty in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM, Öhl L, Rauh M, Schöfl C, Dörr HG.
    Horm Res Paediatr; 2011 Nov 01; 76(6):400-10. PubMed ID: 22123283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.